OWN Your Health and Hologic’s Project Health Equality Collaborate to Produce Culturally Competent Health Information, Research and Care Pathways to Serve the Unique Needs of Black Women

Oprah Winfrey Network and its first-ever health initiative OWN YOUR HEALTH announced today an exclusive partnership with Hologic’s Project Health Equality public health initiative.

About the Health Partnership

The partnership will bring awareness to the disparity of healthcare U.S. Black women receive in the areas of breast, cervical, and uterine fibroids; provide access to education and preventative tools using Hologic’s comprehensive research and resources; and share original content from celebrated OWN creative visionaries highlighting the authentic stories and voices of Black women. View here.

Key insights from leading public health, academic, and professional health organizations indicate that healthcare in the United States is a critical social justice issue that will require collective resources to eradicate. The facts are clear:

Black women are 40% more likely to die from breast cancer.*

Black women experience higher mortality rates from cervical cancer than any other racial or ethnic group.**

Black women are 2x as likely to die from cervical cancer than white women.***

Black women are 2.4x more likely to undergo a hysterectomy for uterine fibroids.****

Black women are 3x more likely to be hospitalized for fibroid-related issues as white women.*****

“As a global leader in women’s health, one of our top priorities is to ensure the women we serve have access to life-changing and life-saving care and resources,” said Karleen Oberton, Hologic’s chief financial officer. “It is more important than ever to address health disparities for Black women – and there is no better partner than OWN to make real change happen. With our resources and OWN’s reach and resonance, we are steadfast in our commitment to serve Black women everywhere.”

“COVID-19, societal pressures and the ongoing racial justice movement have highlighted that stark disparities continue to exist regarding affordable and accessible healthcare, systemic racism, and racial discrimination in healthcare, especially for Black women.” said Jennifer Giddens, head of marketing at OWN. “We are proud to announce this important partnership that supports awareness and action to Black women to own their whole health – physical, mental and emotional as it has never been more critical to use OWN’s wide-reaching platform to meet our audience where she is with support, tools and resources to prioritize her health and wellness.”

The Epidemic Within The Pandemic

The COVID-19 pandemic raised broad awareness of how Black women – and Black communities — have been disproportionately impacted by the virus. This is also the case for other health conditions. In many health areas, Black women experience lower preventive screening rates and follow-up care than other ethnic groups and, accordingly, may be diagnosed with illness at a later stage.

Additionally, Black health disparities often exist as a result of unique stressors such as systemic racism within and outside of the United States healthcare system, racial segregation of neighborhoods, racism-related chronic psychosocial stress and medical mistrust. The OWN YOUR HEALTH and Hologic Project Health Equality partnership addresses the physical, mental and social/emotional aspects of health for and about Black women.

Key Healthcare Issues for Black Women in America:

To inform the campaign, OWN is implementing a study to identify key healthcare issues, attitudes, and behaviors affecting Black women in America. The study includes questions about Black women’s experience of bias in healthcare settings, the impact of past trauma on receiving care, their existing relationships with healthcare providers, and inquiry into cervical, breast, and uterine health and screenings.

References

mm6540a1.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdcpc%2Fresearch%2Farticles%2Fbreast_cancer_rates_women.htm

**https://www.cancer.gov/about-cancer/understanding/disparities

***https://www.contemporaryobgyn.net/view/addressing-the-cervical-cancer-screening-disparities-gap

****https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787340/#:~:text=In%20addition%2C%20African-American%20women,of%20undergoing%20uterine-sparing%20myomectomy.

*****https://bwhi.org/2019/04/03/its-not-normal-black-women-stop-suffering-from-fibroids/#:~:text=Relative%20to%20white%20women%2C%20black,black%20women%20than%20white%20women.

 

 

 

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”